Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.

作者: Fu Peng , Liang Xiong , Hailin Tang , Cheng Peng , Jianping Chen

DOI: 10.1007/S13277-016-5334-1

关键词:

摘要: Breast cancer is a malignant disease to treat among female worldwide due its high capability metastasize and mutate. Epithelial-mesenchymal transition one of the essential processes involved in metastatic capacity breast cancer. In recent time, studies demonstrate that microRNAs, kind small non-coding RNA molecules, could be served as negative regulators cancer, regulating cell cycle, drug resistance, process metastasis development. With assistance microRNA profiling, study concentrating on regulatory function miRNAs investigated more effectively efficiently. More have an important role play EMT modulate metastasis. This essay purpose demonstrating significance detection oncogenes tumor suppress genes through miRNA profiling according reports mainly 5 years, providing evidence efficient target therapy effective pro-diagnosis focusing expression patients.

参考文章(131)
Parham Jabbarzadeh Kaboli, Asmah Rahmat, Patimah Ismail, King-Hwa Ling, MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacological Research. ,vol. 97, pp. 104- 121 ,(2015) , 10.1016/J.PHRS.2015.04.015
Wei Hua, Ke-Di Sa, Xiang Zhang, Lin-Tao Jia, Jing Zhao, An-Gang Yang, Rui Zhang, Jing Fan, Ka Bian, MicroRNA-139 suppresses proliferation in luminal type breast cancer cells by targeting Topoisomerase II alpha. Biochemical and Biophysical Research Communications. ,vol. 463, pp. 1077- 1083 ,(2015) , 10.1016/J.BBRC.2015.06.061
Jianting Long, Caiwen Ou, Haoming Xia, Yifan Zhu, Dayue Liu, MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression Tumor Biology. ,vol. 36, pp. 8697- 8702 ,(2015) , 10.1007/S13277-015-3623-8
Xin Ge, Pengwei Lyu, Zhang Cao, Jingruo Li, Guangcheng Guo, Wanjun Xia, Yuanting Gu, Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting. Biochemical and Biophysical Research Communications. ,vol. 463, pp. 1115- 1121 ,(2015) , 10.1016/J.BBRC.2015.06.068
Tianjing Zheng, Jinjiang Chou, Feng Zhang, Yu Liu, Haiwei Ni, Xiaoman Li, Lufeng Zheng, Tingting Tang, Liang Jin, Tao Xi, CXCR4 3'UTR functions as a ceRNA in promoting metastasis, proliferation and survival of MCF-7 cells by regulating miR-146a activity. European Journal of Cell Biology. ,vol. 94, pp. 458- 469 ,(2015) , 10.1016/J.EJCB.2015.05.010
Julia Liz, Manel Esteller, lncRNAs and microRNAs with a role in cancer development. Biochimica et Biophysica Acta. ,vol. 1859, pp. 169- 176 ,(2016) , 10.1016/J.BBAGRM.2015.06.015
Nairi Abedi, Samira Mohammadi-Yeganeh, Ameneh Koochaki, Fariba Karami, Mahdi Paryan, miR-141 as potential suppressor of β-catenin in breast cancer. Tumor Biology. ,vol. 36, pp. 9895- 9901 ,(2015) , 10.1007/S13277-015-3738-Y
A De Cola, S Volpe, M C Budani, M Ferracin, R Lattanzio, A Turdo, D D'Agostino, E Capone, G Stassi, M Todaro, C Di Ilio, G Sala, M Piantelli, M Negrini, A Veronese, V De Laurenzi, miR-205-5p -mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance Cell Death and Disease. ,vol. 6, ,(2015) , 10.1038/CDDIS.2015.192
Yan-Qiu Song, Xiao-Heng Xu, Da-Wei Li, Hui Feng, Hong-Mei Chen, MiR-300 regulate the malignancy of breast cancer by targeting p53. International Journal of Clinical and Experimental Medicine. ,vol. 8, pp. 6957- 6966 ,(2015)
Xilong Wang, Guoqiang Zhang, Zhenlin Yang, Shujian Xu, Qiang Gao, Wenxiu Qiu, MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway. International Journal of Clinical and Experimental Pathology. ,vol. 8, pp. 5017- 5025 ,(2015)